Silicon Valley Innovations, Inc. – FDA Inspection, Apr 4, 2025

Record Details

This FDA Inspection record concerns Silicon Valley Innovations, Inc., with an inspection on April 4, 2025, issued by the San Francisco District Office, covering human drugs.

Company: Silicon Valley Innovations, Inc.
Inspection Date: April 4, 2025
Product Type: Human Drugs
Office: San Francisco District Office
People: Aranjeet Singh (Company Rep)
Rowena S. Nguyen (Issuing Officer)

View Company Profile

ID · 66fe9833-0425-4653-ac5f-ecd37d33f29b

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number: 1266465
FDA center: Human Drugs
Project area: Drug Quality Assurance
Outcome: Form 483 issued

FDA Citations

21 CFR 211.198(a)Complaint Handling Procedure
21 CFR 211.166(a)(1)Sample size - test intervals

Full citation text and observation details available on the Dashboard.

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Silicon Valley Innovations, Inc.

FDA Inspection

Silicon Valley Innovations, Inc.April 4, 2025